peak

PEAK, a subsidiary of URUS, is the world’s premier cattle genetics supplier. PEAK leads the industry in developing the most profitable genetics and produces the largest amount of bovine semen in the world. The PEAK team specializes in genetics, semen production, quality control, cattle management, research and development, and much more. Using the knowledge and skills of these individuals, PEAK, together with their partners and customers, creates the most powerful and profitable dairy and beef cattle in the world.

Mission Statement

To develop sustainable cattle for global clients using exceptional animal care and innovative technologies to provide superior genetics and high fertility semen.

Gregg Topoleski serves as Chief Financial Officer for URUS. With over 23 years in Finance, he has developed a deep operational and strategic skillset that will complement the URUS leadership team. Before joining URUS, most recently, Gregg served as a Finance Executive for Exact Sciences and 3M/KCI. He started his career with GE in the Healthcare and Industrial Technologies divisions.

Petra Vijverberg is Chief Integration Officer of URUS. She brings with her experience as Managing Director Volkswagen and Sr Vice President of Strategy & Business Development of the PON group. At URUS she leads the coordination, alignment, and innovation of People Development & HR, IT, Digital Strategy, Marketing & Global Development, Corporate Development, and Supply Chain & Logistics.

Kevin Muxlow is Chief Operating Officer for URUS. He has a leadership focus on A.I. sales channels, SCCL, and VAS businesses while also building culture and strategy and supporting growth across the URUS Group. Kevin started with the company in 2005 in marketing, people development, and sales leadership roles.

Paul Hunt is the Chief Executive Officer of URUS. He took on this role after serving as the COO of URUS, where he provided leadership and support to GENEX, PEAK, and the URUS aspects of Corporate Development, People Development, and Distribution. Prior to the creation of URUS, Paul was the Alta Genetics COO since 2004. Paul has spent his entire career within URUS and its predecessors.